Table 2.

Blood product administration by area.

Blood Transfusion Totals by Area of Administration	Group 1A (n = 11) [mean ± SD or median (Q1, Q3)]	Group 1B (n = 11) [mean ± SD or median (Q1, Q3)]	Wilcoxon p Value	Group 2A (n = 4) [mean ± SD or median (Q1, Q3)]	Group 2B (n = 4) [mean ± SD or median (Q1, Q3)]	Wilcoxon p Value
Product administration before separation from CPB
PRBC (mL)	483.6 ± 130.8	778.2 ± 279.6	.01	70 ± 140	75 ± 150	NS
	560 (280, 560)	780 (560, 840)		.0 (.0, 140)	.0 (.0, 150)
FFP (mL)	265.4 ± 3.41	263.2 ± 20.3	NS	66.0 ± 132.0	.0 ± .0	NS
	265 (265, 265)	262 (250, 274)		.0 (.0, 132)	.0 (.0, .0)
Anesthesia administration in operative theater
PRBC (mL)	300 ± 201.8	356.4 ± 220	NS	910.0 ± 925.1	.0 ± .0	NS
	280 (120, 560)	280 (280, 560)		560 (280, 1540)	.0 (.0, .0)	.053
FFP (mL)	194.8 ± 168.3	152.3 ± 191.2	NS	1374.5 ± 1215.4	.0 ± .0	NS
	201 (55, 290)	.0 (.0, 292)		1082.5 (610, 2139)	.0 (.0, .0)	.054
PLTS (mL)	139.2 ± 131.0	82.5 ± 48.4	NS	334.3 ± 334.8	.0 ± .0	NS
	120 (70, 155)	60 (50, 125)		271.5 (110, 558)	.0 (.0, .0)
Cryo (mL)	14.6 ± 16.9	7.0 ± 16.0	NS	128.5 ± 182	.0 ± .0	NS
	.0 (.0, 32)	.0 (.0, .0)		64 (.0, 257)	.0 (.0, .0)
ICU blood product administration
PRBC (mL)	197.3 ± 149.2	375.0 ± 361.2	NS	2049 ± 2963	75 ± 150	NS
	210 (60, 330)	280 (80, 490)		877 (317, 3780)	.0 (.0, 150)
FFP (mL)	43.9 ± 64.9	171.5 ± 188.9	NS	1373 ± 1937	120.8 ± 241.5	NS
	27 (.0, 60)	90 (.0, 362)		625 (259, 2488)	.0 (.0, 241)
PLTS (mL)	32.7 ± 54.4	51.5 ± 64.4	NS	416.3 ± 693.6	.0 ± .0	NS
	.0 (.0, 60)	25 (.0, 90)		110 (.0, 832)	.0 (.0, .0)
Cryo (mL)	21.6 ± 21.2	6.6 ± 14.8	NS	56.8 ± 113.5	.0 ± .0	NS
	30 (.0, 40)	.0 (.0, .0)		.0 (.0, 113)	.0 (.0, .0)

Group 1A, rFVIIa, <30 kg; group 2A, rFVIIa, >30 kg; group 1B, no rFVIIa, <30 kg; group 2B, no rFVIIa, >30 kg.

Wilcoxon signed rank test for paired samples p value.

NS, not significant.